See the DrugPatentWatch profile for Medrol
What patent covers Medrol, and who owns it?
Medrol is the brand name for methylprednisolone, a corticosteroid. Whether a specific Medrol product is covered by an active patent depends on the exact formulation and market (for example, different patents can cover the active drug substance, manufacturing process, or specific dosage forms). The provided information does not include any patent numbers, assignees, or product-specific details for Medrol, so a precise “which patent” answer can’t be verified here.
When does the Medrol patent expire?
Patent expiry dates vary by patent family (drug substance vs. formulation vs. method of use), country, and whether any exclusivity extensions apply. Without identified Medrol patent numbers or jurisdiction, the expiry timeline cannot be stated accurately from the information available.
Is Medrol still protected by patents, or are generics available?
Methylprednisolone has long been a widely used generic medicine in many markets, which typically indicates that drug-substance protection has largely ended. However, some countries or specific product presentations (strengths, pack sizes, or formulations) can have different patent or regulatory protections. The provided information does not confirm which country or which Medrol presentation you mean, so this can’t be resolved precisely.
Which filings could block generic Medrol (patents vs. exclusivity)?
Generic competition can be constrained by either:
- active patents tied to the brand product (for example, formulation or manufacturing patents), and/or
- regulatory exclusivity that can delay approval even after patents expire.
To identify what applies to Medrol, you need the relevant jurisdiction and the specific Medrol product (strength and dosage form).
How to look up the exact Medrol patent quickly
To find the exact patent(s) relevant to Medrol, the fastest approach is to search by:
- “Medrol” and “methylprednisolone” in the patent office for your country, and
- the specific product details (tablet vs. dose pack vs. injectable, strength, and manufacturer/labeler).
If you tell me your country and which Medrol product (e.g., tablets strength, injection vs. tablets), I can narrow down what patents are most likely relevant and what to check for expiry.
What I need from you to give a specific patent answer
Reply with:
1) Your country (US, EU/UK, Canada, etc.)
2) The Medrol product form/strength (tablet strength and whether it’s the injectable, dose pack, etc.)
3) If you’re asking about a specific patent number you saw (paste it)
Then I can map which patent family is tied to that product and explain the likely expiry/entry-for-generics implications based on the identifiable patents.
Sources
No sources were provided in the prompt.